Mackenzie Financial’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,876
| Closed | -$2.37M | – | 1504 |
|
|
2021
Q2 | $2.37M | Sell |
12,876
-3,709
| -22% | -$637K | ﹤0.01% | 694 |
|
|
2021
Q1 | $2.54M | Buy |
16,585
+3,971
| +31% | +$614K | ﹤0.01% | 648 |
|
|
2020
Q4 | $1.97M | Sell |
12,614
-6,680
| -35% | -$858K | ﹤0.01% | 609 |
|
|
2020
Q3 | $2.21M | Sell |
19,294
-1,353
| -7% | -$146K | 0.01% | 540 |
|
|
2020
Q2 | $2.32M | Buy |
20,647
+15,307
| +287% | +$1.63M | 0.01% | 525 |
|
|
2020
Q1 | $479K | Buy |
5,340
+1,475
| +38% | +$145K | ﹤0.01% | 803 |
|
|
2019
Q4 | $418K | Buy |
+3,865
| New | +$413K | ﹤0.01% | 892 |
|
|
2018
Q4 | – | Sell |
-1,867
| Closed | -$260K | – | 1278 |
|
|
2018
Q3 | $260K | Sell |
1,867
-2,594
| -58% | -$325K | ﹤0.01% | 1020 |
|
|
2018
Q2 | $554K | Buy |
4,461
+152
| +4% | +$17.8K | ﹤0.01% | 769 |
|
|
2018
Q1 | $480K | Buy |
4,309
+1,159
| +37% | +$139K | ﹤0.01% | 746 |
|
|
2017
Q4 | $377K | Buy |
3,150
+1,072
| +52% | +$131K | ﹤0.01% | 724 |
|
|
2017
Q3 | $292K | Buy |
+2,078
| New | +$282K | ﹤0.01% | 564 |
|
|
2017
Q1 | – | Sell |
-39,900
| Closed | -$4.88M | – | 720 |
|
|
2016
Q4 | $4.88M | Buy |
+39,900
| New | +$4.88M | 0.03% | 280 |
|
|
2016
Q3 | – | Sell |
-100,735
| Closed | -$11.8M | – | 885 |
|
|
2016
Q2 | $11.8M | Sell |
100,735
-12,447
| -11% | -$1.77M | 0.07% | 236 |
|
|
2016
Q1 | $15.8M | Buy |
113,182
+89
| +0.1% | +$13.1K | 0.14% | 161 |
|
|
2015
Q4 | $21.6M | Buy |
113,093
+909
| +0.8% | +$159K | 0.13% | 157 |
|
|
2015
Q3 | $17.5M | Sell |
112,184
-16,116
| -13% | -$2.94M | 0.11% | 186 |
|
|
2015
Q2 | $23.2M | Buy |
128,300
+29,870
| +30% | +$5.15M | 0.13% | 171 |
|
|
2015
Q1 | $17.1M | Buy |
98,430
+270
| +0.3% | +$48.9K | 0.09% | 205 |
|
|
2014
Q4 | $18.2M | Sell |
98,160
-33,110
| -25% | -$6.14M | 0.09% | 181 |
|
|
2014
Q3 | $21.8M | Sell |
131,270
-2,650
| -2% | -$435K | 0.11% | 172 |
|
|
2014
Q2 | $20.9M | Sell |
133,920
-1,820
| -1% | -$287K | 0.1% | 191 |
|
|
2014
Q1 | $20.6M | Sell |
135,740
-9,330
| -6% | -$1.48M | 0.1% | 182 |
|
|
2013
Q4 | $19.3M | Buy |
145,070
+6,020
| +4% | +$722K | 0.1% | 189 |
|
|
2013
Q3 | $16.2M | Sell |
139,050
-15,000
| -10% | -$1.65M | 0.08% | 205 |
|
|
2013
Q2 | $14.2M | Buy |
+154,050
| New | +$14.8M | 0.07% | 222 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM